NLS Pharmaceutics Ltd. Gains 35.08%
Fri, Oct 27, 2023 at 07:32 PM
NLS Pharmaceutics Ltd. (NLSP:NASDAQ) rocketted at $0.69, representing a gain of 35.1%. On Fri, Oct 27, 2023, NLSP:NASDAQ hit a New 2-Week Intraday Low of $0.5. The stock got featured on our News Catalysts scanner on Thu, Oct 12, 2023 at 12:49 PM in the 'PATNERSHIP' category. From Fri, Oct 13, 2023, the stock recorded 20.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Jul 05, 2023 at $1.53 with a volume of 1M+.
About NLS Pharmaceutics Ltd. (NLSP:NASDAQ)
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders.
Top 10 Gainers:
- Forbion European Acquisition Corp. (FRBN:NASDAQ), 59.33%
- Athersys, Inc. (ATHX:NASDAQ), 59%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 56.86%
- Apollomics Inc. (APLM:NASDAQ), 51.76%
- Signature Bank (SBNY:NASDAQ), 40.85%
- NerdWallet Inc. (NRDS:NASDAQ), 40.66%
- Fangdd Network Group Ltd. (DUO:NASDAQ), 35.98%
- NLS Pharmaceutics Ltd. (NLSP:NASDAQ), 35.08%
- Integrated Media Technology Limited (IMTE:NASDAQ), 29.32%
- BIO-key International, Inc. (BKYI:NASDAQ), 28.88%